Podcasts about Monitoring

Nitroglycerine is vasodilator that affects peripheral blood vessels and coronary arteries.Because of its widespread dilation effects on blood vessels, nitro can quickly lower a patient's blood pressure, sometimes to the point of making a patient hypotensive.Assessment of vital signs prior to administering nitro is necessary to ensure patient safety.Indications for use of nitroglycerine.Nitroglycerine's contraindications & considerations for use.Effects of nitro on patients taking PDE inhibitors.Administration of nitroglycerine to patients with ischemic chest pain.Considerations for patients that took their home nitroglycerine.Monitoring patient's pain and vital signs after nitro administration.Good luck with your ACLS class!Links: Buy Me a Coffee at https://buymeacoffee.com/paultaylor Practice ECG rhythms at Dialed Medics - https://dialedmedics.com/Free Prescription Discount Card - Download your free drug discount card to save money on prescription medications for you and your pets: https://safemeds.vipPass ACLS Web Site - Episode archives & other ACLS-related podcasts: https://passacls.com@Pass-ACLS-Podcast on LinkedIn

Scott Banda, co-founder of Climit, and Ali Cheloei, president of Abbey Commercial Flooring, a commercial flooring contractor in the Washington, D.C. area, discuss the benefit of using Climit site monitoring on job sites to ensure site conditions are within spec before the flooring is installed.

In May 2024, 100 strange rocky structures were installed along Tauranga's harbour shoreline. These flower-shaped artificial rockpools, nicknamed 'sea pods', provide prime waterfront real estate for marine life – from colourful sea slugs to sneezing sponges. Justine Murray finds out how 'living sea walls' are bringing back biodiversity to urban harbours around the world, and joins a marine scientist to check out what creatures have moved into Tauranga's sea pods.Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.In this episode:00:49 – What is a sea pod?06:27 – Living sea walls in Sydney with Dr Aria Lee10:25 – Sea pods around the world and in Tauranga13:06 – Monitoring marine life in the sea pods with David Culliford20:50 – Port of Tauranga21:48 – Looking for critters in the sea pods…Go to this episode on rnz.co.nz for more details

Jerry Ratcliffe on UVA monitoring ACC exit fees + Carla Williams podcast by Ed Lane

#486 What if you could grow your business from zero to $2 million in under a year? In this episode, host Brien Gearin sits down with Sam Preston, founder of Service Scalers, to uncover the strategies, tools, and mindset that fueled the incredible success of his home service digital marketing agency. You'll get a front row seat as they dive into key topics like the secrets to scaling fast, the importance of niching down, and how leveraging local service ads (LSA) can drive business growth. Whether you're looking to start an agency of your own, or you're a seasoned owner who wants to refine your approach to lead generation, this episode is a must-listen! (Original Air Date - 9/23/24) What we discuss with Sam: + Sam's journey to $2M agency growth + Niching down for easier scaling + Local service ads (LSA) as a lead gen game changer + Optimizing Google Business Profile for better leads + Monitoring and improving lead quality with call tracking + Marketing, sales, fulfillment, and recruitment teams + Common digital marketing pitfalls and solutions + Using AI tools like ChatGPT for content and strategy + Retaining clients with transparency and results Thank you, Sam! Check out Service Scalers at ⁠ServiceScalers.com⁠. Follow Sam on ⁠Twitter⁠. Watch the ⁠video podcast⁠ of this episode! To get access to our FREE Business Training course go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠MillionaireUniversity.com/training⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. And follow us on: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tik Tok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To get exclusive offers mentioned in this episode and to support the show, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠millionaireuniversity.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Want to hear from more incredible entrepreneurs? Check out all of our interviews ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Learn more about your ad choices. Visit megaphone.fm/adchoices

Monitoring potential dangers, such as intruders or eavesdroppers, is the focus of the country's new space squadron. Air Component Commander, Air Commodore Andy Scott spoke to Ingrid Hipkiss.

In this episode of the Samson Strength Coach Collective, host Connor Agnew sits down with Nick DaCosta, Assistant Strength and Conditioning Coach at Appalachian State University. Nick opens up about his climb from intern to coach at the same university, and what lessons he's carried with him along the way. He discusses his work with diverse teams—like field hockey and cheer—his takeaways from the Starting Strength Seminar, and how continuous learning has shaped his approach. For Nick, trust and adaptability aren't just buzzwords—they're the keys to long-term success.Adaptability is essential in navigating different sports and athlete needs.Trust is the foundation of athlete-coach relationships.Mentorship significantly impacts career development.Working with international athletes requires cultural sensitivity.Continued education helps coaches stay relevant and effective.Understanding sport-specific demands improves training outcomes.Personal fitness goals enhance coaching credibility.Monitoring athlete load is vital for preventing injury.Strong staff bonds enhance collaboration and morale.Learning from seminars and practical experience is invaluable.“That was the biggest thing for me is just building the trust with them… Once that was instilled in their minds and they were like, wow, this is actually awesome for us… that's where you build that.”— Nick DaCostaKey Takeaways:Quote:

This NDSU Ag Minute features Miranda Meehan, NDSU Extension Livestock Stewardship Specialist. Meehan discusses the importance of maintaining good water quality for livestock throughout the summer months. See omnystudio.com/listener for privacy information.

In this episode of the MamasteFit Podcast Birth Stories, Feige shares her 2 birth stories, detailing her transition from an unplanned C-section in her first birth to preparing for a VBAC in her second pregnancy. Despite meticulous preparation involving choosing a different provider, exercising, and maintaining a healthy diet, she faced an emergency C-section the day before her due date due to decreased fetal movement. Prompted by her husband and recalling advice from the podcast, she went to the hospital, a decision that ultimately saved her baby's life. This episode emphasizes the importance of monitoring fetal movements, trusting maternal intuition, and the impact of supportive care teams.00:00 Introduction to Feige's Birth Stories01:08 The Importance of Monitoring Baby's Movements02:24 Introduction to the Podcast Hosts03:48 Feige's First Birth Experience08:59 Preparing Differently for the Second Pregnancy18:13 Changes and Challenges in the Third Trimester22:28 A Mother's Intuition22:46 Middle of the Night Worries23:47 Emergency Decision24:28 Rushing to the Hospital25:14 Monitoring and Concerns26:04 Facing the Reality26:48 The C-Section Decision30:16 A Scary but Beautiful Moment32:50 NICU and Recovery37:27 Reflecting on the Experience39:56 Empowerment and Gratitude45:06 Final Thoughts and Advice——————————Get Your Copy of Training for Two on Amazon: https://amzn.to/3VOTdwH

Host: Darryl S. Chutka, M.D. Guests: David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S. An early diagnosis of inflammatory bowel disease is important in preventing long-term complications. Prompt treatment can improve quality of life, reduce the likelihood of hospitalizations, and help maintain remissions. However, establishing a diagnosis is often challenging due to the nonspecific and fluctuating nature of symptoms. Inflammatory bowel disease can also mimic other GI conditions. In addition, diagnostic confirmation usually requires a combination of blood tests, imaging, endoscopy, and histological analysis, making the process both time consuming and complex.  The topic for today's podcast is “Diagnosing Inflammatory Bowel Disease and Monitoring Modalities” and my guests are David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S., from the Division of Gastroenterology and Hepatology at the Rochester campus of the Mayo Clinic. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease   Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts   

Wastewater monitoring is a valuable, efficient, and robust tool that public health officials can use to guide public health decision making across the nation. When we turn on the tap or flush the toilet, we often don't think about where all that water goes.  Wastewater, the used water from our homes, schools, and businesses, holds valuable information about the health of our community. Wastewater monitoring can help cities manage wastewater effectively and also creates a safer, healthier, and more responsive living environment for their communities. This blog takes a closer look at five important things to know about wastewater monitoring and how it can help city leaders ensure the health of their communities.   1. Wastewater is more than just water  Wastewater is a mix of bits and pieces that go down our drains – soap, food bits, medicines, toilet paper, and even poop. When this mix is let loose into the environment without proper cleaning, it can mess up our lakes, rivers, and oceans. And not only that, it can be bad for our health too.  ​ 2. Wastewater monitoring gives communities a health checkup  ​ Just as doctors examine us to catch early signs of illness, experts examine wastewater to see what's in it. They look for things like diseases that can affect our health. Wastewater monitoring data can help city leaders identify disease spread early and take steps to keep everyone safe.   ​ 3. Wastewater monitoring is an early warning system for disease spread   ​ Wastewater holds clues about outbreaks of diseases like COVID-19, polio, flu, and more before they happen. When experts test wastewater, they can notice if diseases are starting to spread more. This helps them catch possible outbreaks early and take action to keep everyone safe. They don't leave anyone out—every home, business, and neighborhood connected to the sewage system is included in the process.   ​ 4. Monitoring wastewater involves sampling, testing, and analysis   ​ Sampling: Small amounts of wastewater are collected from different points in the treatment process. Experts use these samples to see what's in the water.  Testing: Using various tools and equipment, they test the samples to find out the levels of chemicals, bacteria, and other substances.  Analysis: Experts analyze the data to understand the changes in disease spread and whether new diseases are starting to appear. Analysis results enable city leaders to make proactive decisions to protect community health and well-being.   5. Wastewater monitoring is a special tool for city leaders that benefits everyone ​City leaders can use information from monitoring wastewater to make important decisions that protect the health of everyone in their communities. Wastewater monitoring data can help city leaders:     Talk to the public in better ways  Promote actions to keep the community safe (like wearing masks and staying apart)  Send medical tests, vaccines, and treatments to the people and places that need them the most  Make sure hospitals and clinics have enough staff  Wastewater might not be dinner table conversations, but it impacts our lives more than we realize. Wastewater monitoring is an important tool that can help city leaders make good decisions and take early action to prevent disease spread to keep the people they serve healthy. So, next time you flush, remember that what you send down the drain has important information that can help create and maintain healthy communities where everyone thrives.   About the authors: Sara Zeigler and Aliyah Ali are freelance writers at the National League of Cities. This article is a product of NLC's partnership with WastewsterSCAN. The National League of Cities (NLC) is partnering with WastewaterSCAN, a national initiative to monitor wastewater for a growing list of infectious diseases including COVID-19 and its variants, flu, and RSV gives communities reliable, sensitive, and actionable data to help them make public health decisions. As a national partner, NLC is raising awareness about the important role of wastewater monitoring in guiding public health responses, creating learning opportunities for NLC members interested in wastewater monitoring, and sharing information with communities across the country about WastewaterSCAN. CREDITS: https://www.nlc.org/article/2023/08/23/5-essential-things-you-need-to-know-about-wastewater-monitoring/

Happy Tuesday! The guys talk about how your mindset changes when you turn 50. Also, what is the latest from the NBA Free Agency and what have the Lakers done so far? The LeBron of it all is still up in the air. Will he request a trade? In a statement put out over the weekend by his team said "...we are closely monitoring the situation." what does that mean? With or with out LeBron how can the Lakers improve the roster? and D'Marco takes us into the FARR SIDE. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of #WorkTrends, join us as we discuss how hiring, screening, and monitoring online behavior are changing in today's world of work. As digital natives make up a growing portion of the workforce, employers must adopt savvy processes to ensure safety, uphold culture, and align online activity with organizational standards. Do you know what you need to know? Do you have the right tech to effectively keep employees safe? Tune in for this very insightful conversation!

In Episode 297, it's all about safe listening levels, hearing protection and more, as Sean and Andy talk to three of the folks behind the Healthy Ears, Limited Annoyance Initiative (HELA) about all things loud (but not too loud)! This episode is sponsored by Allen & Heath and RCF.Returning guest Laura Sinnott, AuD is joined by Jon Burton and Jos Wilder to explain where HELA came from, its purpose, and much more. From World Health Organization standards for live event audio to which generic fit earplugs to recommend to friends, there's a ton of great info in this jam-packed hour.Healthy Ears, Limited Annoyance is a non-profit group of industry and academic specialists in audio, acoustics, and more, offering training and certification about the benefits of responsible sound management.Created in response to research conducted by the World Health Organization (WHO) and the Audio Engineering Society (AES), and hosted by the Electro-Acoustics Research Lab (EARLab), University of Derby, UK, HELA offers training and certification for everyone involved in the live event sector, from bar managers and security staff to sound technicians and concert promoters. It's designed to provide a clear understanding of the benefits of having a responsible sound management plan for audiences, staff and neighbors.HELA supports venues of all sizes, from grassroots to large-scale events, in creating positive relationships with their audiences as well as surrounding communities. Topics covered include the Fundamentals Of Sound, Noise Pollution, Sound Level Limits, Personal Hearing Protection, Management & Communication, Audience Expectations, Venue Design and more.Episode Links:Healthy Ears, Limited Annoyance Initiative (HELA) FAQsWHO Global Standard For Safe Listening Venues & EventsASI Audio 3DME Active-Ambient TechnologyEtymotic Research ER20XS EarplugsCurvd Everyday EarplugsLaura Sinnott, AuD: Choosing Earplugs, Loop Earplugs Review, Curvd Earplugs ReviewSTN Episode 177: Hearing Health MattersSTN Episode 152: Dr. Heather Malyuk, Soundcheck Audiology – “All Ears Are Famous”Episode 297 TranscriptAES Papers:Education and Certification in Sound Pressure Level Measurement, Monitoring and Management at Entertainment EventsSound Level Monitoring at Live Events, Part 1– Live Dynamic RangeSound Level Monitoring at Live Events, Part 2 — Regulations, Practices, and PreferencesSound Level Monitoring at Live Events, Part 3 — Improved Tools and Procedures

LongPath Technologies has taken Nobel-winning discoveries, and applied them to a key cause of climate change: methane leaks from oil and gas facilities. The sector now turns to LongPath to establish monitoring across facilities. But as LongPath sought to scale from innovation to commercialization, it turned to Red Pitaya for a vital component. In this... The post #335 Monitoring Methane: The Tech Behind the Tech  first appeared on Engineering Matters.

Welcome to Ask Stago, the podcast dedicated to provide expert answers to your expert questions in coagulation.  In today's episode, our guest Doctor Isabelle Gouin-Thibault will discuss the influence of dextran sulfate in anti-Xa assay.  Literature sources:  Lasne, D. et al. (2023) Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin. Thrombosis and Haemostasis, 123 (12), 1105.  Hardy, M. et al. (2023) Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring. Res Pract Thromb Haemost. 7 (8), 102257      Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice. 

In this edition of Plan Sea, hosts Anna Madlener and Wil Burns sit down with Kyla Westphal and Mallory Ringham from Ebb Carbon to discuss Project Macoma — the company's pilot ocean alkalinity enhancement (OAE) study being conducted in Port Angeles, Washington this summer. A first-of-its-kind endeavor, Project Macoma aims to remove up to 1,000 tonnes of  CO2 from the atmosphere using Ebb Carbon's electrochemical OAE technology. Kyla and Mallory join to share more about their journey engaging the local community on this proposed research, securing a permit from the U.S. Environmental Protection Agency (EPA), and establishing Monitoring, Reporting, and Verification (MRV) standards as this work gets underway. Project Macoma continues the work of the late Dr. Matthew Eisaman, Co-Founder of Ebb Carbon and a pivotal figure in the ocean-based carbon dioxide removal (oCDR) field. Matt dedicated his life to fostering a clear understanding of the scientific path forward for potential oCDR solutions, while also creating an inclusive and environmentally-responsible sector. For more background into Ebb Carbon and a deep dive into their approach, listen to our episode with Matt HERE. Kyla Westphal, Vice President of External Affairs at Ebb Carbon, joins Anna and Will to discuss her role developing safe and responsible deployment of OAE. Building on her experience working in what she calls “the intersection between technology and humanity,” Kyla oversees both the stakeholder engagement and ecological safety aspects of Ebb Carbon's work. She shares how Project Macoma is building on years of foundational environmental research and engagement with Washington state regulators, community groups, and tribal governments to earn local buy-in and support. Mallory Ringham, Lead Oceanographer and Head of MRV, then discusses how Ebb Carbon secured the first-ever National Pollutant Discharge Elimination System (NPDES) approval for oCDR under the Clean Water Act. She shares how the permit requires a slow, careful, and continuously monitored operation to ensure water quality standards are met within prescribed mixing zones. Mallory also discusses how Ebb's foundational research created a strong understanding of the seasonal and tidal variability in the region, allowing for more accurate monitoring and analysis of the project. This summer, Mallory will continue to oversee the monitoring process to ensure the project is operating safely, responsibly, and effectively.Plan Sea is a semi-weekly podcast exploring ocean-based climate solutions, brought to you by the Carbon to Sea Initiative & the American University Institute for Responsible Carbon Removal.ACRONYMS / CONCEPTS:MRV (1:05); Monitoring, Reporting and VerificationNPDES (14:56); National Pollutant Discharge Elimination SystemMCDR; Marine Carbon Dioxide Removal  (21:58)Plan Sea is a semi-weekly podcast exploring ocean-based climate solutions, brought to you by the Carbon to Sea Initiative & the American University Institute for Responsible Carbon Removal.

In this episode, hosts Kerrin and Taylor dive into three stories with one goal: powering our world with curiosity, creativity, and just a dash of “What if it fails?” Listen in to explore:Updates to NREL's risk management framework. Remember the HERO-WEC from last episode? Researchers are working with the team behind this device to help developers identify, prioritize, and address the challenges of designing and deploying wave energy converters.How NREL engineer Bri Friedman will deploy a new underwater wave energy converter. As she prepares to take the SURF-WEC to Hawaii, Friedman is embracing early challenges as a way to accelerate learning and share open data with the marine energy community. Plus,Insights into how researchers are fast-tracking battery diagnostics with AI. NREL's new physics-informed neural network can predict battery health nearly 1,000 times faster than traditional models, combining the speed of AI with the accuracy of physics—and it's available for free!This episode was hosted by Kerrin Jeromin and Taylor Mankle, written and produced by Allison Montroy, Hannah Halusker, and Kaitlyn Stottler, and edited by James Wilcox, Joe DelNero, and Brittany Falch. Graphics are by Brittnee Gayet. Our title music is written and performed by Ted Vaca and episode music by Chuck Kurnik, Jim Riley, and Mark Sanseverino of Drift BC. Transforming Energy: The NREL Podcast is created by the U.S. Department of Energy's National Renewable Energy Laboratory in Golden, Colorado. Email us at podcast@nrel.gov. Follow NREL on X, Instagram, LinkedIn, YouTube, Threads, and Facebook.

Climate change has brought forth extreme fire events, like the Palisade and Eaton fires in Los Angeles, which devastated communities in Altadena and the Pacific Palisades in the beginning of 2025. And it's becoming harder to not wonder: Is this just the world we live in now? Under the constant threat of catastrophic fires? Fortunately, we have the perfect guests to answer that question. We traveled to NASA's Goddard Space Flight Center and spoke with two of their scientists who study fires from space.Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Idiopathic intracranial hypertension (IIH), a condition of increased intracranial pressure (ICP), causes debilitating headaches and, in some, visual loss. The visual defects are often in the periphery and not appreciated by the patient until advanced; therefore, monitoring visual function with serial examinations and visual fields is essential. In this episode, Kait Nevel, MD speaks with John J. Chen, MD, PhD, and Susan P. Mollan, MBChB, PhD, FRCOphth, authors of the article “Treatment and Monitoring of Idiopathic Intracranial Hypertension” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Chen is a professor of ophthalmology and neurology at the Mayo Clinic in Rochester, Minnesota. Dr. Mollan is an honorary professor of metabolism and systems science in the department of neuro-ophthalmology at University Hospitals Birmingham in Birmingham, United Kingdom. Additional Resources Read the article: Treatment and Monitoring of Idiopathic Intracranial Hypertension Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Guests: @chenmayo, @DrMollan Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today, I'm interviewing Drs John Chen and Susan Mollan about their article on treatment and monitoring of idiopathic intracranial hypertension, which appears in the June 2025 Continuum issue on disorders of CSF dynamics. Drs Chen and Mollan, welcome to the podcast. And please, could you introduce yourselves to the audience? Dr Chen: Hello, everyone. I'm John Chen, one of the neuro-ophthalmologists at the Mayo Clinic. Thanks for having us here. Dr Mollan: Yeah, it's great to be with you here. I'm Susan Mollan. I'm a consultant neuro-ophthalmologist in Birmingham, England. Dr Nevel: Wonderful. So great to have you both here today, and our listeners. To start us off, talking about your article, can you share with us what you think is the most important takeaway from your article for the practicing neurologist out there? Dr Chen: Yeah, so our article talked about the treatment and monitoring of IIH. And I think one takeaway point is, IIH is becoming much more prevalent now that there's this worldwide obesity epidemic with obesity having- essentially being the largest risk factor for IIH other than female. It's really important to monitor vision because vision loss is often peripheral vision loss at first, which the patient may be completely unaware of. And so, it's important to pair up with an ophthalmologist so you can monitor the papilledema of the visual fields and make sure they don't get permanent vision loss. And in the article, we also talk about- there's been changes in the treatment of severe IIH, where traditionally, we used VP shunts; but there's been a trend toward using more venous sinus stenting in addition to the traditional surgeries. Dr Nevel: Great, thank you. I think probably most of our listeners or a lot of neurologists out there have a pretty good understanding of kind of the basics of the IIH. But can you kind of just go over a few key characteristics of IIH, and maybe some things that are less commonly known or things that are maybe just been kind of better understood over the past decade, perhaps? Dr Mollan: Yes, certainly. I think, as Dr Chen said, it's because this condition is becoming more prevalent, people recognize it. I think it's- we like to go back to the diagnostic criteria so that we're making a very accurate diagnosis. So, the patients may come in to the emergency room with, say, papilledema that's been identified elsewhere or crashing headaches. And it's important to go through that sort of diagnostic pathway, taking a blood pressure, taking a full blood count to make sure the patient is anemic, and then moving forward with that confirmation of papilledema into urgent neuroimaging, whether it's CT or MRI, but including venography to exclude a venous sinus thrombosis. And then if you have no structural lesion that's causing the raised ICP, it's moving forward with your lumbar puncture and carefully checking those pressures. But the patients may not only have crashing headache, they often have pulsatile tinnitus and neck pain. I think some of the features that we're now recognizing is the systemic metabolic effects that are unique to IIH. And so, there's an increased risk of cardiometabolic disease that's over and above what is conferred by obesity. Also, our patients have a sort of maternal health burden where they get impaired fertility, gestational diabetes and preeclampsia. And there's also an associated mental health burden, amongst other things. So we're really starting to understand the spectrum of the disease a bit more. Dr Nevel: Yeah, thank you for that. And that really struck me in your article, how important it is to be aware of those things so that we're making sure that we're managing our whole patient and connecting them with the appropriate providers for some of those other issues that may be associated. For the practicing neurologist out there without all the neuro-ophthalmology equipment, if you will, what should our bedside exam focus on to help us get maybe an early but accurate picture of the patient's visual function when we suspect IIH to be at play, perhaps before they can get in with the neuro-ophthalmologist? Dr Chen: Yeah, I think at the bedside you can still check visual acuity and confrontational visual fields, you know, with finger counting. Of course, you have to know that those are, kind of, crude kind of ways of screening. With papilledema, oftentimes the visual acuity is intact. And the confrontational visual fields aren't as sensitive as automated perimetry. Another important thing will be to do your direct ophthalmoscope and look at the amount of papilledema. If it's grade one or two papilledema on the more mild side, it's actually not vision threatening. It's the higher degrees of papilledema that can cause rapid vision loss. And so, if you look in and you see grade one papilledema, obviously you need to do the full workup, the MRI, MRV, lumbar puncture. But in terms of rapidly getting to an ophthalmologist to screen for vision loss, it's not going to be as important because you're not going to have vision loss at that low grade. If you look in and you see this rip-roaring papilledema, grade five papilledema, that patient is going to be at very severe risk of vision loss. So, I think that exam, looking at the optic nerve can be very helpful. And of course, talking to the patient about symptoms; is there decreased vision Is there double vision from a sixth nerve palsy? Are there transient visual obscurations which would indicate at least a higher degree of papilledema? That'd be helpful as well. Dr Nevel: Great, thank you. And when the patient does get in with a neuro-ophthalmologist, you talk in your article and, of course, in clinical practice, how OCT testing is important to monitor in this condition. Can you provide for the listeners the definition of OCT and how it plays a role in monitoring patients with IIH? Dr Mollan: Sure. So, OCT is short for optical coherence tomography imaging, and really the eye has been at the forefront of OCT alone. Our sort of cardiology colleagues are catching up on the imaging of blood vessels. But what it allows us to do is give us really good cross-sectional, anatomical-level changes that we can see both in the retina and also at the optic nerve head. And it gives us some really good measurements. It's not so good at sort of saying, is this definitely papilledema or not? That sort of lower end of disc elevation. But it is very good at ruling out what we call the pseudopapilledema. So, things like drusens or these other little masses we find underneath the optic nerve head. But in terms of monitoring, because we can longitudinally take these images and the reproducibility is pretty good at the optic nerve head, it allows us to see whether there's direct changes: either the papilledema getting worse or the papilledema getting better at the optic nerve head. It also gives us some indication of what's going on in the ganglion cell layer complex. And that can be helpful when we're thinking about sort of looking at structure versus function. So, ophthalmologists in general, we love OCT; and we spend much more time nowadays looking at the OCT than we really do the back of the eye. And it's just become critical for patients with papilledema to be able to be very accurate from visit to visit to see what's changing. Dr Nevel: How do you determine how frequently somebody needs to see the neuro-ophthalmologist with IIH and how often they need that OCT evaluation? Dr Chen: Once the diagnosis of IIH is made, how often they need to be seen and how frequent they need to be seen depends on the degree of papilledema. And again, OCT is really nice. You can quantify it and then different providers can actually use the same OCT numbers, which is super helpful. But again, if it's grade three papilledema or higher, or article thickness of 200 or higher, I tend to follow them a little bit more closely, trying to treat them more aggressively. Try to get the papilledema down into a safer zone. If it's grade one or two papilledema, we see them less frequently. So, my first visit might be three months out. They come with grade five papilledema, I'm seeing them within a few days to make sure that's papilledema's come down quickly because we're trying to decide, are they going to need surgery or not? Dr Nevel: Yeah, great. And that's a nice segue into talking a little bit about how we treat patients with IIH after the diagnosis is confirmed. And I'd like to just point out you have a very lovely figure in your article---Figure 5-6,---that I'd like to direct our listeners to read your article and check out that figure, which is kind of an algorithm on how we think about the various treatment options for patients who have IIH, which seems to rely a lot on the degree of presence of papilledema and the presence of vision disturbance. Could you maybe walk us through a little bit about how you think about the different treatment options for patients with IIH and when more urgent surgical intervention might be indicated? Dr Mollan: Yeah, sure. We always find it quite hard in any medical specialty to write these kind of flow diagrams because it's really an individual we're looking at. But these are kind of what we'd say is “broad brushstrokes” into those patients that we worry about, sort of, red disease in those patients, more amber disease. Now obviously, even those patients that may not have severe papilledema, they may have crashing headaches. So, they may be an urgent referral themselves because of that. And so, it's nice to try and work out which end of the spectrum you're working with. If we think of the papilledema, Dr Chen's already laid out the sort of lower end of the prison's scale---our grades one, our grades two---that we're less anxious about. And those patients, we would definitely be having discussions about medical management, which includes acetazolamide therapy; but also thinking about weight management. And it may well be that we talk a little bit further about weight management, but I think it's helpful to sort of coach those conversations after you've made a definite diagnosis. And then laying out the risk that's caused, potentially, the IIH in an individual. And then having a sort of open conversation with them about what changes they can have in their lifestyle alongside thinking about medical therapy. There's some patients with very low levels of papilledema that we decide not to put on medicines initially. As patients progress up that papilledema grade, we're definitely thinking about medical therapy. And our first line from the IIH treatment trial would be using acetazolamide, but we need to be thinking about using appropriate dosing. So, a lot of the patients that I see can be sent to me with very low doses that may be inappropriate for that person. In the IIHTT they used up to four grams daily in a divided dose. And you do need to counsel your patients when you're putting them on acetazolamide because of the side effects. You've got quite a nice table in this article about the side effects. I think if you get the patient on board, that they understand that they will experience side effects, that is helpful because they will expect it, and then possibly tolerate it a bit better. Moving through to that area where we're more anxious, that visual-threatening papilledema. As Dr Chen said, it's sort of like you look in and it's sort of “blood and thunder” in there. And you need to be getting on and encouraging the ophthalmologist to get a formal assessment of the visual field. It's very difficult to determine exactly the level at which- and we talk about the mean deviation in a lot of our research studies. But in general, it's a combination of things: the patient's journey to get to you, their symptoms, what's going on with the visual field, but what's also happening at the OCT. So, we look in and we see that fluid is seeping towards the fovea. We get very anxious, and those patients may not even have enough time for a rapid escalation of acetazolamide. It may well be at the first presentation, which we would term, like, fulminant; that we'd be thinking about surgical intervention. And I think before I stop, the other thing to say is, the surgical landscape is really changing. So, we're having some good studies coming out in terms of stenting. And so, there is a sort of bracket where it may well be that we are thinking about neuroradiological intervention in an earlier case. They may not quite be at that visual-threatening stage, but they may be resistant to medical treatments. Dr Nevel: Thank you for that. What do you think is a potential pitfall or a mistake to avoid, if you will, in the management of patients with IIH? Dr Chen: I think it's- in terms of pitfalls, I think the potential pitfalls I've seen are essentially patients where we don't necessarily create a good patient physician relationship. Where they don't have buy-ins on the treatment, they don't have buy-ins to come back, and they're lost to follow-up. And these patients can be dangerous, because they could have vision threatening papilledema and if not getting the appropriate treatment---and if they're not monitoring the vision---this can lead to poor outcomes. So, I've definitely seen that happen. As Dr Mollan said, you really have to tell them about the side effects from the medications. If you just take acetazolamide, letting them know the paresthesias and the changes in taste and some of these other side effects, they're going to immediately stop the medication. Again, and these medications do work, proven in the IIH treatment trial. So again, I think that patient-physician relationship is very important to make sure they have appropriate follow up. Dr Nevel: The topic of weight loss in this patient population can be tricky, and I know I talked with Susie in a prior interview about how to approach this topic with our patients in a sensitive and compassionate manner. Once this topic is broached, I find many patients are looking for advice on strategies for weight loss, or potentially medications or other interventions. How do you prioritize or think about the different weight loss strategies or treatments with your patients, and how do you think about the way that you recommend these different treatments or not? Dr Mollan: Yeah. I think that's a really great question because we sort of stray here into a specialty that we have not been trained in. One thing I definitely ask my patients: if they've been on a weight loss journey before, and what's worked for them and what's not worked for them. And within our different healthcare systems, we have access to different tiers of weight management approaches. But for the person sitting in front of me, that possibly there may be a long journey to access more professional care, it's about understanding. iIs there things that are free, such as, we have some apps in the National Health Service which are weight management applications where they can actually just start putting in their calories, their daily calorie intake. And those apps can be quite helpful and guiding in terms of targeting areas, but also informing the patient of what types of foods to avoid in their diet and what types of foods to include in their diet. And with some of the programs that are completely complementary, they also sometimes add on things about exercise. But I think it is a really difficult thing to manage as, say, an ophthalmologist or a neurologist, mainly because it's not our area of expertise. And I think we've all got to find, in our local hospitals and healthcare systems, those pathways where the patients may be able to access nutritional support, and sort of behavioral lifestyle therapy support, all the way through to the new medications for weight loss; and also for some people, bariatric surgery pathways. It's a tricky topic. Dr Nevel: So how should we counsel our patients about what to expect in the future in terms of visual outcomes? Dr Chen: I think a lot of that depends on the degree of papilledema when they present. If a patient comes in with grade five papilledema, that fulminant IIH that Dr Mollan had mentioned, these patients can have very severe vision loss. And even if we treat them very aggressively with high-dose medications and urgent surgical interventions, sometimes they can have permanent vision loss. And so, we counsel them that, you know, there's a strong chance that they're going to have a good amount of vision loss. But some patients, we're very surprised and we get a lot of vision back. So, we kind of set expectations, but we're cautiously optimistic that we can get vision back. If a patient presents with more mild papilledema like grade one or two papilledema, they're most likely not going to have any permanent vision loss as long as we're treating them, we're monitoring their vision, they're coming to their follow-ups. They tend to do very well from a vision perspective. Dr Nevel: That's great, thank you. And you know, ties into what you said earlier about really making sure that, you know, we create good- as with any patient, but good physician-patient relationships so that they, you know, trust us and they come to follow up so we can really monitor their vision appropriately. What do you think is going on in research in this area that's exciting? What do you think one of the next breakthroughs or thing that we need to understand the most about treatment and monitoring of IIH? Dr Chen: I think surgically, venous sinus stenting is going to probably take over the bulk of surgeries. We still need that randomized clinical trial, but we have some amazing outcomes with venous sinus stenting. And there's many efforts on randomized clinical trials for venous sinus stenting. So we'll have those results soon. From a medical standpoint, Dr Mollan can actually say, actually, more about this. Dr Mollan: I completely agree. The GLP-1 receptor agonists, the twofold prong approach: one is the weight loss where these patients, you know, have significant weight loss to put their disease into remission; and the other side of it is whether certain GLP-1s have the ability to reduce intracranial pressure. So, a phase 2 study that we undertook here in Birmingham did show that we were able to reduce intracranial pressure, but we don't think it's a class effect. So, I think the sort of big breakthrough will be looking at novel therapies like xenotide and other drugs that, say, work on the proximal kidney tubule. Are they able to reduce intracranial pressure directly? And I think we are on the cusp of a real breakthrough for this disease. Dr Nevel: Great. Thank you so much for chatting with me today. And I really learned a lot, appreciated the opportunity. I hope our listeners learned something today, too. So again, today I've been interviewing Drs John Chen and Susan Mollan about their article on treatment and monitoring of idiopathic intracranial hypertension, which appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Teddy body suits, Tapple, Candle wax nipple, The poop-knife, Blood pressure monitoring whilst eating Creme Brûlée

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, but How Far?" by Zeynep B. Zengin et al. published on February 28, 2025. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Natalie DelRocco: Hello, and welcome to JCO Precision Oncology Article Insights. I'm your host, Natalie DelRocco, and today we will be discussing the editorial, "Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, but How Far?" This editorial by Zengin and Kotecha discusses the impact of circulating tumor DNA (ctDNA) and its potential applications in renal cell carcinoma - we'll call this RCC for the remainder of the podcast. This article was published in February of 2025, and I think this is really timely because ctDNA is currently an emerging biomarker of interest in many different cancers. Having shown promise in certain cancers, other types of cancers are really targeting ctDNA to see if it can be used as a prognostic or a predictive biomarker in their specific field of oncology. Sometimes it is found that ctDNA is a prognostic marker that's associated with outcome, but it's not always clear whether it is a predictive biomarker that can help modify treatment and to what extent it could be helpful modifying treatment. This is what the authors of this editorial really focus on. They focus on the applications of ctDNA in RCC by interpreting the accompanying article, "Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma" by Basu et al. So, the editorial authors begin by giving examples of cancers where ctDNA has been shown to be useful in cancer monitoring - for example, locally advanced urothelial carcinoma - and they give examples of when it has not been shown to be useful in monitoring colorectal cancer. And this just highlights the variability of ctDNA as a biomarker. It's not always a useful biomarker, but sometimes it is. The authors note that RCC may fall into the latter category - that is, the "not useful" category - due to the low ctDNA shedding which characterizes RCC. However, metastatic RCC - we'll call this ‘mRCC' for the remainder of the podcast - may be a target for use of ctDNA clinically due to advanced assay development, according to the authors. Basu et al, in the original work that the editorial accompanies, showed in a retrospective study of 92 patients with mRCC that ctDNA detectability was associated with poorer PFS, regardless of receipt of active treatment versus no receipt of active treatment. That's important because ctDNA can be directly affected by therapy. The authors of the editorial believe that this is a particularly promising result for a few reasons. Firstly, the estimated hazard ratios were quite large. A hazard ratio of 3.2 was seen in the active treatment group versus a hazard ratio of 18 was observed in the no-active-treatment group. I will note that a hazard ratio of 18 with an extremely wide confidence interval is an unusual observation. So, when interpreting this result, I would consider the direction and magnitude of the effect to be suggestive of promise but needing to be validated in the future to improve precision. And the authors of the editorial do agree with this; they note the same. The authors also note that a single-patient example was used to show how that ctDNA positivity can be used in mRCC to monitor and prompt imaging if disease progression is suspected. And then that way, disease progression can be caught earlier. That to say, there is a real target for clinical use, which isn't always the case. Sometimes we know that ctDNA is associated with outcome, but we don't quite know how we can modify when we know that ctDNA is positive. In this case, the editorial authors show that we can use ctDNA positivity to monitor patients for disease progression. Despite the promise of the study, the editorial does highlight that the study inherits typical retrospective study limitations. For example, there is a heterogeneous cohort. There is variability in data collection, particularly nailing down specific time points, which can always be a challenge when collecting biological samples as part of a study. And small sample size - although 92 patients is great for renal cell carcinoma, it is a challenging sample size with respect to precision of those hazard ratio estimates, which we've already talked about. The authors additionally note that ctDNA could be used to direct therapy, not just to monitor for disease progression. So, both monitoring and changing therapy would certainly require further study and validation, which is discussed by the authors of this editorial. We would want larger, prospective studies showing the same association before we would be comfortable modifying treatment for patients based on their ctDNA positivity level. Thank you for listening to JCO Precision Oncology Article Insights. Don't forget to give us a rating or a review, and be sure to subscribe so that you never miss an episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Spurs Chat: Discussing all Things Tottenham Hotspur: Hosted by Chris Cowlin: The Daily Tottenham/Spurs Podcast Hosted on Acast. See acast.com/privacy for more information.

(0:00) Matt McCarthy begins Hour #2 reacting to comments made by former Red Sox Pitcher, Pedro Martinez highlighting the downfall and dysfunctional perception the Red Sox are earning by trading away homegrown Hall of Fame talent. McCarthy continues to highlight the latest Jeff Passan reporting on the Red Sox' internal dysfunction. (10:48) McCarthy breaks down comments made by Craig Breslow regarding the team post-Devers trade. McCarthy holds Breslow in a higher regard than Bloom. More excerpts from the latest Passan piece on Boston. McCarthy discerns that a purge in the front office was warranted and defends Breslow becoming a more empowered General Manager. McTakey manages to take down Theo Epstein's disciples and recommendations. (24:53) McCarthy reports on the Red Sox lineup posted for today's game that features Jarren Duran leading off at DH and Roman Anthony playing LF. Monitoring the Red Sox lineup going forward. McTakey puts Jarren Duran on the trading block if/when the Red Sox become sellers. Talk about the Red Sox youth movement. (33:43) McCarthy follows up on the extensive Jeff Passan report on the Red Sox, this time - Kristian Campbell and his start at 2B on the big league ballclub to begin the season. McTakey rips the team for their premature gloating over Campbell's hot start to the year. ------------------------------------------- FOLLOW ON TWITTER/X: @MattMcCarthy985 | @jorgiesepulveda

Sharon Samjitsingh is an asthma patient and developer of the ADAMM wearable device and Nightingale emergency respiratory care services. She has suffered with asthma her entire life and as a child, fear surrounded her and her family never knowing when the next attack would occur. As an adult she decided to do something to help others monitoring their breathing rhythms, heart rate and symptoms by developing a wearable technology that is taped under the torso and data relayed to a smartphone or computer via wifi that send alerts of an upcoming attack far in advance of its presentation. Her team of on call respiratory therapists then coach the patient with breathing education and behavior modification to reduce likelihood of presentation of an attack. Her results have changed the life of an asthma, COPD, ILD, and Cystic Fibrosis patient from a life caged by fear to one of empowering freedom and self-control. For review of the studies, visit healthcareoriginals.com

Samotics is pioneering a revolutionary approach to industrial asset monitoring, delivering condition, performance, and energy efficiency insights for hard-to-reach industrial equipment without requiring sensors to be installed on the machines themselves. Founded by Simon Jagers, the company has developed Electrical Signature Analysis (ESA) technology that monitors over 10,000 machines by analyzing electrical data captured remotely, enabling companies to prevent unplanned downtime and save 10-20% energy without compromising performance. In this episode of Category Visionaries, Simon shares the fascinating journey from a failed AI-first approach to discovering breakthrough technology that's now being integrated with ABB drive systems to create the data fabric for smart factories of the future. Topics Discussed: The evolution from data-driven AI approach to hardware-enabled sensorless monitoring How railway switch monitoring led to the breakthrough discovery of remote electrical signature analysis Samotics' strategy of targeting hard-to-reach assets in extreme industrial environments The challenge of creating the "sensorless condition monitoring" category in a vibration-dominated market Building a service-heavy go-to-market model in an AI-first technology company Partnership strategy with ABB to integrate ESA technology into drive systems GTM Lessons For B2B Founders: Target the "either us or nothing" market segments: Simon's breakthrough came from identifying industrial assets operating in extreme conditions where traditional monitoring was impossible or impractical. ArcelorMittal's conveyor moving steel plates across a 1500°C blast furnace exemplified this perfectly - they had two choices: Samotics' unproven technology or no monitoring at all. B2B founders should actively seek market segments where incumbent solutions physically cannot compete, creating natural "blue ocean" opportunities. Focus on unique positioning rather than universal applicability: Initially, Samotics tried to monitor every type of machine possible, believing their AI could handle any scenario. Simon learned to focus specifically on the 25% of rotating equipment that operates in extreme or hard-to-reach conditions where their remote sensing advantage was undeniable and easy to communicate. B2B founders should resist the temptation to be everything to everyone and instead dominate the specific use cases where their solution provides clear, defensible advantages. Embrace service components even in technology-first companies: Despite starting as an AI company with inclinations to automate everything, Samotics discovered that the human service element - having mechanical and electrical experts bridge AI findings with customer needs - became one of their most appreciated product components. They now deliver hardware, AI, and dashboards as a service with regular customer calls and visits. B2B founders should test whether adding high-touch service elements enhances rather than detracts from their technology value proposition. Build category credibility through scale and proof points: Simon emphasizes that category creation requires time, credible data, and real-world examples at scale. With over 10,000 machines monitored, Samotics can now make credible claims about accuracy and effectiveness. The category definition evolved from internal team alignment to external market education. B2B founders attempting category creation must first achieve meaningful scale and documented success before expecting market adoption of their category framework. Use enemy-based positioning strategically in early stages: Samotics initially positioned aggressively against traditional vibration-based monitoring, using humor and edge to grab attention from early adopters who appreciated the contrarian approach. However, Simon notes this was effective primarily for reaching experienced early adopters who understood the technology's limitations but were drawn to unique solutions. B2B founders should consider enemy-based positioning as a tactical tool for early adoption rather than a long-term brand strategy.   //   Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe.  www.GlobalTalent.co   //   Don't Miss: New Podcast Series — How I Hire Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role. Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM   

Scan Messages 6/20/25Additional information: Lebanon, Northern Palestine, Syria and parts of Turkey could be significant.

Join the conversation with C4 & Bryan Nehman.  C4 & Bryan kicked off the show this morning discussing the state audit on home monitoring. Trump & Iran.  The side hustle is alive and well as many struggle to make ends meet in the economy.  Judge Andrew Arthur joined the show discussing immigration.  Former Governor Bob Ehrlich joined the show as well talking about his new book Revolution, Redemption, Revival, Trump 2.0.  Listen to C4 & Bryan Nehman live weekdays from 5:30 to 10am on WBAL News Radio 1090, FM 101.5 & the WBAL Radio App.

In this episode, we dive into the vital role of Measurement, Monitoring, Reporting, and Verification (MMRV) in the success of Carbon Capture, Utilization, and Storage (CCUS) projects. Joined by experts Pramit Basu and Sergey Kotov from Baker Hughes, we explore why MMRV is more than just a regulatory checkbox—it's a foundational pillar for long-term storage security, risk mitigation, and market credibility in the evolving carbon economy.

Part of my Redgate work is with customers who need to monitor their database servers. With estates growing quickly, both in scale and types of database platforms used, keeping an eye on everything can be challenging. Add in the lack of staff growing as quickly are the number of servers, and I find many companies seeking out monitoring tools to better help them manage the entire estate.. When someone evaluates a tool, one of the first questions from many people is about load. They are concerned about the load a tool puts on the system, which is always some amount. Most tools say they use less than 2% of total resources, some might hedge at 5%. Hopefully, there's no more impact than 5%, though that might seem to high, especially if you have a busy database server already. Read the rest of Multiple Monitoring Tools

(00:00-24:53) – Query & Company opens on a Wednesday with Jake Query and producer Eddie Garrison discussing the latest on Tyrese Haliburton’s calf strain. They play what Rick Carlisle said on the Fan Morning Show. Also, they touch on last night’s chippy win for the Indiana Fever over the Connecticut Sun. (24:53-39:47) – Will Carroll joins Jake Query to explain what Tyrese Haliburton is currently dealing with. He highlights the three different types of strains that he could have, notes how long it would typically take someone to recover from the various degrees, doesn’t see a correlation between his calf strain and a potential achilles tear like Damian Lillard or Kevin Durant, and he provides some context around the shoulder soreness that Anthony Richardson is dealing with right now. (39:47-43:46) – The first hour of the program concludes with Jake and Eddie discussing which three NBA franchise would most likely relocate to Seattle to bring back the Supersonics. (43:46-1:09:49) – Former Indiana Pacer and Seattle Supersonics player, Sam Perkins, joins Query & Company to discuss what he has seen from his two former franchises in the NBA Finals, reminiscences on his time playing for Team USA underneath Bob Knight, his relationship with Michael Jordan at North Carolina, and explains what his transition from the Western Conference to joining the Pacers in the Eastern Conference. (1:09:49-1:20:31) – During his conversation with Sam Perkins, Rick Carlisle and Tyrese Haliburton met with the media following Pacers practice ahead of game six of the NBA Finals. Jake plays what they have to say about his availability for game six. It leads to a minor debate between Jake and Eddie. (1:20:31-1:27:52) – The second hour of today’s show wraps up with Jake and Eddie discussing last night’s scuffles between Caitlin Clark and Jacy Sheldon/Marina Mabry. Jake makes a comment about Clark that goes against the norm. (1:27:52-1:56:43) – Pacers radio sideline reporter and Fever play-by-play broadcaster, Pat Boylan, tips of the final hour of Query & Company by discussing last night’s Fever game and all of the antics that occurred during the game. He also comments on where the Pacers are at right now mentally heading into game six of the NBA Finals and reacts to a breaking news story about former Purdue All-American Zach Edey. (1:56:43-2:05:51) – With the big topic of the day being the status of Tyrese Haliburton for tomorrow’s game six, Jake replays what Rick Carlisle and Tyrese said about his availability for game six. (2:05:51-2:13:29) – Today’s show closes out with JMV joining Jake and Eddie in the studio to weigh in on the conversation about Caitlin Clark and the events that occurred during the win last night for the Fever.Support the show: https://1075thefan.com/query-and-company/See omnystudio.com/listener for privacy information.

I. Glenn Cohen is a professor of law and deputy dean at Harvard Law School and faculty director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I.G. Cohen, I. Ajunwa, and R.B. Parikh. Medical AI and Clinician Surveillance — The Risk of Becoming Quantified Workers. N Engl J Med 2025;392:2289-2291.

In this episode of Maximize Your Hunt, host Jon Teater discusses Rocky Burrus SA Farms discusses various strategies for improving hunting properties, including habitat management, timber management, and the impact of solar farms on wildlife. Jon and Rocky Burrus (SA Farms Management) emphasize the importance of understanding deer behavior and creating effective access and road systems to enhance hunting success. The conversation also touches on community concerns regarding land use and the economic implications of solar farms. In this conversation, the speakers discuss various strategies for managing deer habitats to enhance hunting success. They explore the importance of molding deer behavior through habitat management, the strategic use of road systems to influence deer movement, and the creation of safe zones for mature deer. The conversation also touches on the significance of post-season assessments for habitat planning and the ethical considerations surrounding hunting practices, including fair chase principles.   Takeaways: Maximizing hunting properties involves strategic land management. Field conversions can significantly improve deer habitat. Timber management should prioritize wildlife over profit. Access roads are crucial for effective hunting strategies. Creating food sources can attract deer to specific areas. Solar farms can fragment wildlife habitats and impact deer movement. Community concerns about land use are important for local ecosystems. Understanding deer behavior is key to successful hunting. Effective road systems can enhance deer movement and access. Monitoring deer activity through technology can improve hunting success. Molding deer behavior is essential for effective hunting. Strategic road systems can influence deer movement patterns. Creating safe zones can attract mature deer to desired areas. Post-season assessments are crucial for refining habitat management strategies. Ethics in hunting practices should prioritize fair chase and animal welfare. Using natural features can enhance deer movement and access points. Monitoring deer behavior helps in understanding their patterns. Habitat management can lead to increased mature buck sightings. Effective hunting requires a balance between access and deer safety. Utilizing fencing and screens can direct deer movement effectively.   Social Links SA FARMS Management Service | Facebook https://www.instagram.com/safarmmanagementservice/?hl=en https://whitetaillandscapes.com/ https://www.facebook.com/whitetaillandscapes/ https://www.instagram.com/whitetail_landscapes/?hl=en Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Maximize Your Hunt, host Jon Teater discusses Rocky Burrus SA Farms discusses various strategies for improving hunting properties, including habitat management, timber management, and the impact of solar farms on wildlife. Jon and Rocky Burrus (SA Farms Management) emphasize the importance of understanding deer behavior and creating effective access and road systems to enhance hunting success. The conversation also touches on community concerns regarding land use and the economic implications of solar farms. In this conversation, the speakers discuss various strategies for managing deer habitats to enhance hunting success. They explore the importance of molding deer behavior through habitat management, the strategic use of road systems to influence deer movement, and the creation of safe zones for mature deer. The conversation also touches on the significance of post-season assessments for habitat planning and the ethical considerations surrounding hunting practices, including fair chase principles.Takeaways:Maximizing hunting properties involves strategic land management.Field conversions can significantly improve deer habitat.Timber management should prioritize wildlife over profit.Access roads are crucial for effective hunting strategies.Creating food sources can attract deer to specific areas.Solar farms can fragment wildlife habitats and impact deer movement.Community concerns about land use are important for local ecosystems.Understanding deer behavior is key to successful hunting.Effective road systems can enhance deer movement and access.Monitoring deer activity through technology can improve hunting success. Molding deer behavior is essential for effective hunting.Strategic road systems can influence deer movement patterns.Creating safe zones can attract mature deer to desired areas.Post-season assessments are crucial for refining habitat management strategies.Ethics in hunting practices should prioritize fair chase and animal welfare.Using natural features can enhance deer movement and access points.Monitoring deer behavior helps in understanding their patterns.Habitat management can lead to increased mature buck sightings.Effective hunting requires a balance between access and deer safety.Utilizing fencing and screens can direct deer movement effectively. Social LinksSA FARMS Management Service | Facebookhttps://www.instagram.com/safarmmanagementservice/?hl=enhttps://whitetaillandscapes.com/https://www.facebook.com/whitetaillandscapes/https://www.instagram.com/whitetail_landscapes/?hl=en

Step inside the evolving world of fetal therapy where precision, teamwork, and full-spectrum care matter most. In this episode of the BackTable OBGYN Podcast, Dr. Anthony Shanks, Vice Chair of Education in the OB department at Indiana University School of Medicine, interviews Dr. Hiba Mustafa, a distinguished maternal-fetal medicine specialist and fetal interventionalist at Riley Children's Hospital. They discuss Dr. Mustafa's expertise in fetal diagnosis and therapy, her training journey through various fellowships, and her role in directing multiple fetal medicine programs. --- SYNPOSIS Dr. Mustafa elaborates on the intricacies of fetal interventions, including procedures for complications in monochorionic twins, spina bifida repair, and new emerging therapies. They also touch on research methodologies like the Delphi consensus technique and summarize key findings from recent studies on conditions such as hemolytic disease, gastroschisis, lower urinary tract obstructions, and preterm birth in twin pregnancies. Dr. Mustafa shares insights on how to stay sharp in the field, the importance of teamwork in surgical procedures, and advice for those aspiring to enter the field of fetal therapy. --- TIMESTAMPS 00:00 - Introduction02:45 - The Role of a Fetal Interventionalist04:00 - Dr. Mustafa's Training Journey07:42 - Fetal Surgery Fellowships16:43 - Conditions Treated by Fetal Interventionalists21:17 - Monitoring and Referrals for Monochorionic Twins30:04 - Understanding Percutaneous Procedures31:10 - Navigating the Equator in Fetal Surgery32:31 - Laser Surgery Techniques and Outcomes33:18 - The Importance of Placenta Delivery33:47 - In Utero Spina Bifida Repair36:19 - Minimally Invasive Techniques for Spina Bifida38:28 - Maintaining Skills in Fetal Interventions42:11 - Delphi Consensus Technique in Medical Research46:19 - Key Takeaways from Recent Research51:55 - Future of Fetal Therapy and Personal Insights

In the face of insect decline, it is critical for us to understand pollinator health both in terms of influencing factors and how to monitor those impacts. Today we are specifically focusing on bees.To talk about some exciting research in this field is Dr. Laura (la-u-ra) Figueroa (fig-eh-row-ah). Laura is an Assistant Professor in the Environmental Conservation Department at the University of Massachusetts Amherst. She was previously a National Science Foundation post-doctoral research fellow, and completed her PhD in entomology at Cornell University. Laura is broadly interested in insect conservation, with a focus on the health of pollinators in changing landscapes and the impacts of climate change. She has worked in temperate regions (primarily the Northeastern US) as well as in the tropics (in Costa Rica and in Colombia), and her active research program seeks to answer pressing questions in the field of pollinator conservation.---Photo: Sara Morris / CC BY-NC 2.0Thank you for listening! For more information go to xerces.org/bugbanter.

Quantitative waveform capnography is used in ACLS to objectively assess good CPR;confirm placement of an endotracheal tube; identify return of spontaneous circulation; and during post-cardiac arrest care.We can use waveform capnography with, and without, an advanced airway in place.Monitoring end tidal CO2 during rescue breathing.Use of capnography to objectively measure good CPR.Capnography is a preferred method of confirming endotracheal tube (ETT) placement over x-ray during a code.During CPR, a sudden increase in ETCO2 may indicate ROSC.Quantitative waveform capnography use in the post-cardiac arrest algorithm.Good luck with your ACLS class!Links: Buy Me a Coffee at https://buymeacoffee.com/paultaylor Practice ECG rhythms at Dialed Medics - https://dialedmedics.com/Free Prescription Discount Card - Download your free drug discount card to save money on prescription medications for you and your pets: https://safemeds.vipPass ACLS Web Site - Episode archives & other ACLS-related podcasts: https://passacls.com@Pass-ACLS-Podcast on LinkedIn

Get Total Network Visibility today and better understand your network: https://itdad.info/pathsolutionsIn this episode, I sit down with Tim Titus, CTO of  @PathSolutions  , live from the floor at Cisco Live—the world's biggest networking conference. We dive into the evolution of network monitoring and why the tools you choose can make or break not just your infrastructure, but your career as a network engineer. Tim shares real-world insights on what most teams are doing wrong, how visibility gaps lead to major headaches, and what it takes to actually fix them. Whether you're just starting out in networking or deep into your IT career, this conversation will challenge how you think about monitoring.If you've ever wondered if your network tools are helping you—or holding you back—this is a must-watch.

The government has reduced staff and funding at the National Geohazards Monitoring Centre by 25% This comes despite the siesmic activity expierenced throughout the country and the rising frequency of natural disasters, not only in New Zealand but around the world. The Wire producer Samantha sat down with PSA organizer Claire Nickson to discuss the implications of this move and its affects in the public.

Welcome to BCI Cattle Chat! This episode starts off with a research update from BCI student Jordana Zimmermann. She talks about her project on rate of consumption. Next the experts discuss how to monitor herd health in a pasture. Finally the crew is joined by parasite expert, Dr. Brian Herrin to discuss the New World… Continue reading Research Update, Monitoring Cattle, Screwworm

In this episode, Dr. Lauren speaks with the 2024 Shannon O'Boyle Memorial Neuropsychiatric Illness Grant awardees, Tess Levy of the Seaver Autism Center at Mount Sinai and Dr. Pilar Trelles of Boston Children's Hospital. In their project titled, "Adapting PIPS for Progress: Development and Validation of an Ecological Momentary Assessment Tool to Enhance Psychiatric Symptoms, Monitoring and Intervention Response in Phelan-McDermid Syndrome", they address the need for better measurement tools of neuropsychiatric symptoms in Phelan-McDermid syndrome as well as the importance of involving caregivers and medical experts in the process of developing measures. Tune in to hear more about the measure and why it's so needed! Interested in participating in their study and filling out the updated measure? Act fast! They are collecting data for a only a few more days! You can participate here: https://redcap.link/014yntw7Tune in now, and don't forget to subscribe to this podcast so you never miss an episode!

Mark Ericksen, creator of the Elixir LangChain framework, joins the Elixir Wizards to talk about LLM integration in Elixir apps. He explains how LangChain abstracts away the quirks of different AI providers (OpenAI, Anthropic's Claude, Google's Gemini) so you can work with any LLM in one more consistent API. We dig into core features like conversation chaining, tool execution, automatic retries, and production-grade fallback strategies. Mark shares his experiences maintaining LangChain in a fast-moving AI world: how it shields developers from API drift, manages token budgets, and handles rate limits and outages. He also reveals testing tactics for non-deterministic AI outputs, configuration tips for custom authentication, and the highlights of the new v0.4 release, including “content parts” support for thinking-style models. Key topics discussed in this episode: • Abstracting LLM APIs behind a unified Elixir interface • Building and managing conversation chains across multiple models • Exposing application functionality to LLMs through tool integrations • Automatic retries and fallback chains for production resilience • Supporting a variety of LLM providers • Tracking and optimizing token usage for cost control • Configuring API keys, authentication, and provider-specific settings • Handling rate limits and service outages with degradation • Processing multimodal inputs (text, images) in Langchain workflows • Extracting structured data from unstructured LLM responses • Leveraging “content parts” in v0.4 for advanced thinking-model support • Debugging LLM interactions using verbose logging and telemetry • Kickstarting experiments in LiveBook notebooks and demos • Comparing Elixir LangChain to the original Python implementation • Crafting human-in-the-loop workflows for interactive AI features • Integrating Langchain with the Ash framework for chat-driven interfaces • Contributing to open-source LLM adapters and staying ahead of API changes • Building fallback chains (e.g., OpenAI → Azure) for seamless continuity • Embedding business logic decisions directly into AI-powered tools • Summarization techniques for token efficiency in ongoing conversations • Batch processing tactics to leverage lower-cost API rate tiers • Real-world lessons on maintaining uptime amid LLM service disruptions Links mentioned: https://rubyonrails.org/ https://fly.io/ https://zionnationalpark.com/ https://podcast.thinkingelixir.com/ https://github.com/brainlid/langchain https://openai.com/ https://claude.ai/ https://gemini.google.com/ https://www.anthropic.com/ Vertex AI Studio https://cloud.google.com/generative-ai-studio https://www.perplexity.ai/ https://azure.microsoft.com/ https://hexdocs.pm/ecto/Ecto.html https://oban.pro/ Chris McCord's ElixirConf EU 2025 Talk https://www.youtube.com/watch?v=ojL_VHc4gLk Getting started: https://hexdocs.pm/langchain/gettingstarted.html https://ash-hq.org/ https://hex.pm/packages/langchain https://hexdocs.pm/igniter/readme.html https://www.youtube.com/watch?v=WM9iQlQSFg @brainlid on Twitter and BlueSky Special Guest: Mark Ericksen.

The Ultimate Retirement Budgeting Formula Revealed: Secure Your Financial FutureHow much you need to retire quiz: https://adamdolson.com/retire-quiz/In this video, discover a transformative retirement budgeting formula that goes beyond traditional advice. Learn how to categorize your expenses into essential, discretionary, and one-time costs to eliminate financial stress and boost your retirement satisfaction. Get practical tips on estimating expenses, managing taxes, and monitoring your budget to maintain financial security and enjoy your golden years. .00:00 Introduction to Retirement Budgeting00:40 Breaking Down Essential Expenses01:32 Understanding Discretionary Expenses01:59 Planning for One-Time Expenses02:39 Calculating and Adjusting Your Budget04:23 Managing Taxes in Retirement05:06 Monitoring and Adjusting Your Budget06:18 Implementing Your Retirement Spending Plan09:16 Conclusion and Next Steps8043718.1

Patients with a heart rate less than 60 are bradycardic. Some people can have a resting heart rate in the 40s without any compromise. For others, a heart rate of 50 or less could signify the need for immediate intervention and warrants additional assessment.Signs & symptoms that indicate a bradycardic patient is unstable.Monitoring oxygen saturation with pulse oximetry and indications for administration of oxygen.Calcium channel blockers and beta blocker medication as treatable causes of bradycardia.The indications and dosage of Atropine.Precautions for Atropine use in patients with second or third degree AV blocks.The use of transcutaneous pacing (TCP) for unstable bradycardic patients refractory to Atropine.The use and dosing of Dopamine and Epinephrine drips.For additional information about causes and treatment of bradycardia, check out the pod resources page at PassACLS.com.Good luck with your ACLS class!Links: Buy Me a Coffee at https://buymeacoffee.com/paultaylor Practice ECG rhythms at Dialed Medics - https://dialedmedics.com/Free Prescription Discount Card - Download your free drug discount card to save money on prescription medications for you and your pets: https://safemeds.vipPass ACLS Web Site - Episode archives & other ACLS-related podcasts: https://passacls.com@Pass-ACLS-Podcast on LinkedIn

The Perfect Planner for ADHD? Let's Talk Time Systems That Actually WorkIf you've ever thought this planner is going to change my life... only to abandon it weeks later, you are not alone! Today, we're diving into the REAL reason planners often don't work for ADHD brains—and what to do instead. In this video, I walk you through: ✔️ The 3 essential parts of an ADHD-friendly time system✔️ Why your brain shouldn't be your to-do list✔️ How to use a dump list without drowning in it✔️ The importance of retrieval (not just collection)✔️ What to do with “boomerang tasks” that come back later✔️ And why it's 100% okay to switch up your planner (really!)I'll also share how I personally use my system—weekly planning, daily focus, and energy management—to stay ahead of chaos, without running myself into the ground.#ADHDplanner #ExecutiveFunctioning #ADHDtimeManagement #OccupationalTherapist #DumpList #ADHDcoaching #CalmSystems #neurodivergentlife 

The goal of CPR is to keep the brain and vital organs perfused until return of spontaneous circulation (ROSC) is achieved.Post-arrest care and recovery are the final two links in the chain of survival.Identification of ROSC during CPR.Initial patient management goals after identifying ROSC.The patient's GCS/LOC should be evaluated to determine if targeted temperature management (TTM) is indicated.Patients that cannot obey simple commands should receive TTM for at least 24 hours.Recently published studies on TTM and ACLS's current standard.Monitoring the patient's core temperature during TTM.Patients can undergo EEG, CT, MRI, & PCI while receiving TTM.Good luck with your ACLS class!Links: Buy Me a Coffee at https://buymeacoffee.com/paultaylor Practice ECG rhythms at Dialed Medics - https://dialedmedics.com/Free Prescription Discount Card - Download your free drug discount card to save money on prescription medications for you and your pets: https://safemeds.vipPass ACLS Web Site - Episode archives & other ACLS-related podcasts: https://passacls.com@Pass-ACLS-Podcast on LinkedIn

In this episode of The Matt Feret Show I interview Therese Forton-Barnes, a green-living expert, advocate, and business owner. Therese and I discuss her mission of detoxifying American households, and she identifies the top products mindful consumers may want to avoid. Therese shares insight into her process of downsizing toxins in her home and provides helpful resources listeners can explore to learn more about the ingredients in their cleaning supplies, drinking water, and health and beauty products. Watch this podcast on YouTube.Introduction to Therese Forton-Barnes [1:09]Health Starts in the Home with Therese Forton-Barnes [5:46]Products to Minimize in the Home with Therese Forton-Barnes [9:45]Monitoring the Air Quality in Your Home with Therese Forton-Barnes [28:06]Common Air Pollutants in the Home with Therese Forton-Barnes [30:58]Chemical Content of Personal Products with Therese Forton-Barnes [42:17]How to Minimize Chemicals in Water with Therese Forton-Barnes [57:38]Connect with me via the podcast website, LinkedIn, Facebook, and Instagram.Check out Therese's Green Living Guru's website, Instagram, LinkedIn, Amazon storefront.Explore green-living resources Environmental Working Group Tap Water Database, Environmental Working Group, Made-Safe.org. Hosted on Acast. See acast.com/privacy for more information.

The White House pulls Jared Isaacman's nomination, the 2026 NASA budget is released, the Hubble Tension might not be a problem after all, the Milky Way and Andromeda might not merge after all. And on SpaceBites+, which ozone isn't a good biosignature.

Watch every episode ad-free & uncensored on Patreon: https://patreon.com/dannyjones Dr. Epstein is a Harvard trained research psychologist, author of 15 books and more than 250 scientific and mainstream articles, as well as the former editor-in-chief of Psychology Today. SPONSORS https://huel.com/danny - New customers use code DANNY for 15% off your order. http://drinkag1.com/dannyjones - Get started with AG1's Next Gen & notice the benefits for yourself. https://irestore.com - Reverse hair loss & unlock HUGE savings on the iRestore Elite w/ code DANNY. https://whiterabbitenergy.com/?ref=DJP - Use code DJP for 20% off GUEST LINKS https://www.drrobertepstein.com https://americasdigitalshield.com FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - How Google influences everything 08:21 - Mind control research 12:56 - Death threats 25:46 - Who funded Google - and why? 32:59 - How Google infiltrates other search engines 42:33 - 23andMe, Google & DNA harvesting 44:12 - Whistleblower leaks 51:02 - Google's rulebook for content suppression 01:04:22 - The "opinion matching" effect 01:10:06 - 2024 election 01:22:13 - Monitoring big tech's influence 01:28:41 - Foreign countries are scared of Google 01:44:52 - Google's pending lawsuits 01:53:37 - President Eisenhower's farewell address warning 01:55:55 - 7 steps to protect your online privacy 02:01:47 - Indoctrinating children 02:10:38 - The self-censorship issue 02:16:41 - Gemini, Chat GPT & DeepSeek 02:22:31 - Elon Musk & Stephen Hawking's AI warning 02:38:03 - The 3 laws of robotics 02:44:13 - Time travel & the UFO phenomenon 02:47:54 - Neural transduction theory 02:55:43 - Origin of human intelligence Learn more about your ad choices. Visit podcastchoices.com/adchoices

Morse Tan, former ambassador and now leader of the Election Monitoring Team in South Korea, on the latest on election integrity efforts there. @GORDONGCHANG, GATESTONE, NEWSWEEK, THE HILL 1890